Trung Huynh
Stock Analyst at RBC Capital
(4.79)
# 480
Out of 4,355 analysts
294
Total ratings
73%
Success rate
22%
Average return
Main Sectors:
Stocks Rated by Trung Huynh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintained: Buy | $1,250 | $1,105.00 | +13.12% | 23 | May 21, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | n/a | $118.72 | - | 18 | May 21, 2026 | |
| PFE Pfizer | Reiterated: Sell | $25 | $26.18 | -4.51% | 34 | May 5, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Hold | $60 | $57.18 | +4.93% | 19 | Apr 30, 2026 | |
| ABBV AbbVie | Maintained: Buy | $260 | $217.72 | +19.42% | 9 | Apr 29, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Hold | $595 → $660 | $614.78 | +7.36% | 10 | Nov 7, 2025 | |
| JSPR Jasper Therapeutics | Maintained: Buy | $29 → $25 | $0.829 | +2,915.68% | 4 | Aug 15, 2025 | |
| INSM Insmed | Maintained: Buy | $133 → $140 | $106.91 | +30.95% | 10 | Aug 13, 2025 | |
| AMGN Amgen | Maintained: Hold | $326 → $317 | $336.79 | -5.88% | 9 | Aug 6, 2025 | |
| ALXO ALX Oncology Holdings | Maintained: Buy | $1.2 → $1 | $1.90 | n/a | 2 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 → $38 | $31.43 | n/a | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $7 | $3.78 | n/a | 2 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $12 | $8.52 | n/a | 2 | Mar 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $2.60 | n/a | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €10.00 → €13.50 | $9.28 | n/a | 9 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $170 → $175 | $225.33 | n/a | 4 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 700.00 → CHF 580.00 | $500.40 | n/a | 3 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 2,600 | $1,704.00 | n/a | 5 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 350.00 | $329.30 | n/a | 12 | Jul 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €44.00 → €40.00 | $51.50 | n/a | 3 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €14.00 → €12.00 | $11.38 | n/a | 6 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €105.00 | $156.60 | n/a | 6 | Apr 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 670.00 | $295.10 | n/a | 16 | Apr 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €57.00 | $36.53 | n/a | 12 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 9,000p | $13,802.00 | n/a | 13 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $31 | $7.85 | n/a | 2 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | 1,300p → 1,400p | $1,881.50 | n/a | 13 | Jun 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €165.00 | $130.85 | n/a | 12 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €96.00 | $75.29 | n/a | 16 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 90.00 | $117.82 | n/a | 10 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €35.00 | $70.47 | n/a | 1 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 → $73 | $45.58 | n/a | 3 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €83.00 | $244.16 | n/a | 1 | Jul 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.48 | $26.33 | n/a | 2 | Jun 25, 2020 |
Eli Lilly and Company
May 21, 2026
Maintained: Buy
Price Target: $1,250
Current: $1,105.00
Upside: +13.12%
Merck & Co.
May 21, 2026
Reiterated: Buy
Price Target: n/a
Current: $118.72
Upside: -
Pfizer
May 5, 2026
Reiterated: Sell
Price Target: $25
Current: $26.18
Upside: -4.51%
Bristol-Myers Squibb Company
Apr 30, 2026
Maintained: Hold
Price Target: $60
Current: $57.18
Upside: +4.93%
AbbVie
Apr 29, 2026
Maintained: Buy
Price Target: $260
Current: $217.72
Upside: +19.42%
Regeneron Pharmaceuticals
Nov 7, 2025
Maintained: Hold
Price Target: $595 → $660
Current: $614.78
Upside: +7.36%
Jasper Therapeutics
Aug 15, 2025
Maintained: Buy
Price Target: $29 → $25
Current: $0.829
Upside: +2,915.68%
Insmed
Aug 13, 2025
Maintained: Buy
Price Target: $133 → $140
Current: $106.91
Upside: +30.95%
Amgen
Aug 6, 2025
Maintained: Hold
Price Target: $326 → $317
Current: $336.79
Upside: -5.88%
ALX Oncology Holdings
May 21, 2025
Maintained: Buy
Price Target: $1.2 → $1
Current: $1.90
Upside: n/a
May 9, 2025
Maintained: Buy
Price Target: $44 → $38
Current: $31.43
Upside: n/a
Apr 1, 2025
Maintained: Buy
Price Target: $10 → $7
Current: $3.78
Upside: n/a
Mar 29, 2025
Maintained: Buy
Price Target: $13 → $12
Current: $8.52
Upside: n/a
Mar 28, 2025
Maintained: Buy
Price Target: $4
Current: $2.60
Upside: n/a
Aug 24, 2023
Maintained: Hold
Price Target: €10.00 → €13.50
Current: $9.28
Upside: n/a
Jul 20, 2023
Reiterated: Hold
Price Target: $170 → $175
Current: $225.33
Upside: n/a
Dec 7, 2022
Maintained: Buy
Price Target: CHF 700.00 → CHF 580.00
Current: $500.40
Upside: n/a
Aug 11, 2022
Maintained: Hold
Price Target: kr 2,600
Current: $1,704.00
Upside: n/a
Jul 24, 2022
Maintained: Hold
Price Target: CHF 350.00
Current: $329.30
Upside: n/a
May 11, 2022
Maintained: Sell
Price Target: €44.00 → €40.00
Current: $51.50
Upside: n/a
May 10, 2022
Maintained: Hold
Price Target: €14.00 → €12.00
Current: $11.38
Upside: n/a
Apr 13, 2022
Maintained: Hold
Price Target: €105.00
Current: $156.60
Upside: n/a
Apr 1, 2022
Maintained: Hold
Price Target: kr 670.00
Current: $295.10
Upside: n/a
Dec 13, 2021
Maintained: Hold
Price Target: €57.00
Current: $36.53
Upside: n/a
Nov 15, 2021
Maintained: Buy
Price Target: 9,000p
Current: $13,802.00
Upside: n/a
Aug 4, 2021
Maintained: Buy
Price Target: $29 → $31
Current: $7.85
Upside: n/a
Jun 22, 2021
Maintained: Sell
Price Target: 1,300p → 1,400p
Current: $1,881.50
Upside: n/a
May 13, 2021
Maintained: Buy
Price Target: €165.00
Current: $130.85
Upside: n/a
Apr 29, 2021
Maintained: Buy
Price Target: €96.00
Current: $75.29
Upside: n/a
Apr 28, 2021
Maintained: Hold
Price Target: CHF 90.00
Current: $117.82
Upside: n/a
Jan 20, 2021
Maintained: Sell
Price Target: €35.00
Current: $70.47
Upside: n/a
Oct 12, 2020
Maintained: Buy
Price Target: $56 → $73
Current: $45.58
Upside: n/a
Jul 28, 2020
Maintained: Hold
Price Target: €83.00
Current: $244.16
Upside: n/a
Jun 25, 2020
Downgraded: Hold
Price Target: $3.48
Current: $26.33
Upside: n/a